MetaCap

Enliven Therapeutics (ELVN) News

NASDAQ: ELVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.53+0.12 (+0.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ELVN news summary

We found 4 recent headlines mentioning Enliven Therapeutics (ELVN): 0 in the past week and 2 in the past 30 days, most often from PR Newswire, Seeking Alpha, Nasdaq. For price context, ELVN is up 0.26% at $46.53. The most recent story, "Enliven Therapeutics GAAP EPS of -$0.36", was published by Seeking Alpha on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Enliven Therapeutics headlines

Stocks mentioned alongside ELVN

Compare ELVN